Key Points
- Insider Hyong Kim sold 32,479 Alignment Healthcare shares at an average price of $8.30, generating $269,575.70. The sale covered tax-withholding obligations tied to vested equity awards and reduced Kim’s ownership by 9.79%.
- Alignment Healthcare reported quarterly EPS of $0.17, beating estimates by $0.04, while revenue rose 31.6% year over year to $1.34 billion.
- ALHC opened at $8.55 and has fallen below its 50- and 200-day moving averages. Analysts maintain a “Moderate Buy” consensus with a $23 average price target, though some firms recently lowered ratings or targets to “Hold” and $10.
Alignment Healthcare, Inc. (NASDAQ:ALHC - Get Free Report) insider Hyong Kim sold 32,479 shares of the business's stock in a transaction dated Tuesday, October 6th. The shares were sold at an average price of $8.30, for a total transaction of $269,575.70. Following the completion of the sale, the insider owned 299,271 shares in the company, valued at approximately $2,483,949.30. This trade represents a 9.79% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards.
Alignment Healthcare Price Performance
Shares of ALHC opened at $8.55 on Thursday. Alignment Healthcare, Inc. has a 1-year low of $7.37 and a 1-year high of $25.12. The stock has a market cap of $1.77 billion, a PE ratio of 45.00 and a beta of 1.14. The firm has a 50-day simple moving average of $11.84 and a two-hundred day simple moving average of $16.76. The company has a debt-to-equity ratio of 1.22, a current ratio of 1.70 and a quick ratio of 1.70.
Alignment Healthcare (NASDAQ:ALHC - Get Free Report) last issued its quarterly earnings data on Thursday, July 30th. The company reported $0.17 EPS for the quarter, topping the consensus estimate of $0.13 by $0.04. The firm had revenue of $1.34 billion for the quarter, compared to analyst estimates of $1.31 billion. Alignment Healthcare had a net margin of 0.89% and a return on equity of 20.02%. The business's revenue for the quarter was up 31.6% compared to the same quarter last year. During the same period in the prior year, the business posted $0.07 EPS. As a group, analysts forecast that Alignment Healthcare, Inc. will post 0.17 EPS for the current year.
Institutional Inflows and Outflows
A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. Versant Capital Management Inc raised its position in Alignment Healthcare by 463.3% in the 2nd quarter. Versant Capital Management Inc now owns 1,380 shares of the company's stock valued at $33,000 after purchasing an additional 1,135 shares in the last quarter. Nykredit A S acquired a new position in shares of Alignment Healthcare during the second quarter worth about $36,000. Signature Equity Partners LLC acquired a new position in shares of Alignment Healthcare during the first quarter worth about $46,000. GAMMA Investing LLC grew its position in shares of Alignment Healthcare by 46.6% during the second quarter. GAMMA Investing LLC now owns 3,368 shares of the company's stock worth $80,000 after buying an additional 1,070 shares in the last quarter. Finally, Caitong International Asset Management Co. Ltd increased its stake in shares of Alignment Healthcare by 51,757.1% during the fourth quarter. Caitong International Asset Management Co. Ltd now owns 3,630 shares of the company's stock worth $72,000 after buying an additional 3,623 shares during the period. 86.19% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
Several research analysts have recently commented on ALHC shares. UBS Group restated a "neutral" rating on shares of Alignment Healthcare in a research report on Wednesday, July 8th. Wall Street Zen downgraded Alignment Healthcare from a "buy" rating to a "hold" rating in a report on Saturday, August 1st. Barclays decreased their target price on Alignment Healthcare from $16.00 to $10.00 and set an "equal weight" rating on the stock in a research note on Tuesday. Zacks Research downgraded Alignment Healthcare from a "strong-buy" rating to a "hold" rating in a research report on Monday, July 6th. Finally, KeyCorp reiterated an "overweight" rating on shares of Alignment Healthcare in a research note on Wednesday, June 10th. Seven analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus price target of $23.00.
Read Our Latest Stock Analysis on ALHC
Alignment Healthcare Company Profile
(
Get Free Report)
Alignment Healthcare, Inc is a technology-enabled Medicare Advantage company focused on providing health coverage and care services for older adults. The company offers Medicare Advantage plans that combine medical benefits with care coordination, wellness support, and other services designed to help members manage their health.
Alignment operates through an integrated healthcare model that uses its proprietary technology platform to support physicians, care teams, and members. Its services include personalized care management, clinical coordination, virtual and in-home support, and member assistance through its concierge-style approach.
See Also
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
